- ... could be considered for patients who have had hypersensitivity reactions to ... has been used successfully for prevention of CINV in a single cycle of both ...
- ... after an acute coronary syndrome. [2011] 1.4. Drug therapy for secondary prevention NICE has produced a visual summary of the ... failure in adults. We have clarified advice on drug therapy for secondary prevention to indicate that dual antiplatelet therapy may not ...
- ... J, Shuster J, et al.: Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor- ... Extended intrathecal methotrexate may replace cranial irradiation for prevention of ... The Associazione Italiana di Ematologia ed Oncologia Pediatrica. ...
- ... ul> <p class="">Centers for Disease Control and Prevention</p></full-summary><group >Drug Therapy</group><language-mapped-topic >Medicinas para la tos ...
- ... The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review. Eur J ...
- ... description of the pathogen, disease epidemiology, treatment, and prevention. Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy. 2005 Sep;25(9):1193–212. PMID: 16164394. ...
- ... hyperglycemia Hypericum ... radiation ...
- ... to reduce cytotoxic and neurotoxic outcomes.[ 36 ] Dental hypersensitivity may occasionally arise in the weeks or months after the discontinuation of chemotherapy and/or radiation therapy.[ 13 ] Topical application of ...
- ... for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16 (4): 1561-7, 1998. [ PubMed : 9552066 ] Puckrin R, El Darsa H, Ghosh S, et al.: Ineffectiveness of high-dose methotrexate for prevention of CNS relapse in diffuse large B-cell ...
- ... to documentation strategies Bates DW. Frequency, consequences and ... ER. Latex hypersensitivity. Journal of Pharmaceutical Care in Pain and Symptom ...
41 results